Meloknot 7.5 Tablet contains Meloxicam 7.5mg, a preferential COX-2 inhibiting non-steroidal anti-inflammatory drug (NSAID) indicated for the management of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and musculoskeletal pain. It helps in reducing joint inflammation, stiffness, and pain while improving mobility.
Meloxicam works by inhibiting cyclooxygenase enzymes involved in prostaglandin synthesis, thereby reducing pain and inflammation with a comparatively improved gastrointestinal safety profile. The lower strength makes it suitable for long-term therapy and dose-adjusted treatment plans.
For distributors and healthcare suppliers, Meloknot 7.5 Tablet is a high-demand anti-inflammatory and analgesic product, commonly prescribed for early-stage arthritis, maintenance therapy, and elderly patients. Consistent use in chronic joint disorders ensures stable market demand.
Adding Meloknot 7.5 Tablet to your pain management and anti-inflammatory therapy segment creates strong opportunities in pharmacies, hospitals, orthopedic clinics, export markets, and third-party manufacturing. Its balanced efficacy, long-term usability, and strong prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.